News | Radiographic Fluoroscopy (RF) | July 21, 2025

Luminos Q.namix R, Luminos Q.namix T Radiography/Fluoroscopy platforms enable remote and tableside examinations. The platforms switch easily between radiography and fluoroscopy applications and offer streamlined design, intuitive user interface and optimized AI-powered workflows.

Siemens Healthineers Receives FDA Clearance for Two Multifunctional Imaging Platforms

July 21, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for two multifunctional imaging platforms for radiography and fluoroscopy, or real-time 2D imaging: the remote-controlled Luminos Q.namix R and the Luminos Q.namix T with tableside control.

The two new platforms, which can be used for specialized and complex examinations, can simplify workflows at low patient radiation doses through intuitive controls, integrated components, and built-in workflow guidance supported by artificial intelligence (AI). This enhanced efficiency can enable faster procedures, reducing patient wait times and increasing overall productivity.

“With these two new platforms, Siemens Healthineers offers the radiography and fluoroscopy communities a long-sought, user-friendly alternative to imaging systems of unnecessarily complex design, which have been a barrier to more efficient workflows,” said Niral Patel, head of X-ray Products at Siemens Healthineers North America.

Unlike many 2-in-1 rad/fluoro systems, the Luminos Q.namix platforms have a fully integrated, highly intuitive design, which Siemens Healthineers developed over a six-year period with input from more than 160 customers who are fluoroscopy experts. Both platforms feature ergonomic controls and a streamlined touch interface with automated functions for dose and workflow optimization. Functionalities with live camera and AI support enable users to acquire images of consistent quality at a low radiation dose, regardless of their experience level. The new generation of wireless detectors can improve imaging of microstructures in radiography and works with compatible Siemens Healthineers systems and imaging software.

The remote-controlled Luminos Q.namix R can be operated either in the control room to avoid user radiation exposure, or from inside the exam room at the bedside, depending on patient and exam requirements. It is designed for fluoroscopy procedures that include lower and upper gastrointestinal exams, as well as swallow and joint injection studies that require contrast media. It also can be used for radiography exams, including general exams of the chest, bones, and joints; and orthopedic imaging, including automated long leg and long spine imaging. The Luminos Q.namix R’s source-to-image distance (SID) of 180 cm (71 inches) can increase productivity during radiography exams by reducing geometrical distortions caused by the distance between the X-ray tube and detector. The in-room control panel allows the user to operate the system adjacent to the patient table, which can be particularly beneficial for pediatric patients and during certain types of fluoroscopy exams.

The Luminos Q.namix T with tableside control is ideal for non-ambulatory patients and examinations that require intensive patient interaction, including pediatrics, bariatrics, and gastroenterology. Multiple touch panels provide easy access to imaging parameters, while the OptiGrip ergonomic handle lets users save fluoro images or loops without diverting their attention from the task at hand. The digital fluoro tower parks automatically, allowing seamless switching between radiographic and fluoroscopic exams.

Additional information on the Luminos Q.namix platforms can be found at www.siemens-healthineers.com/en-us/fluoroscopy/luminos-qnamix-platform

 


Related Content

News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | Contrast Media

Feb. 23, 2026 — Bracco, a global leader in diagnostic imaging, recently announced that the U.S. Food and Drug ...

Time February 24, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with ...

Time February 20, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Interventional Radiology

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 02, 2026
arrow
News | Computed Tomography (CT)

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...

Time January 23, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
Subscribe Now